Literature DB >> 4842016

The metabolites of oxprenolol (Trasicor) in man.

W Riess, H Huerzeler, F Raschdorf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4842016     DOI: 10.3109/00498257409052112

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


× No keyword cloud information.
  9 in total

Review 1.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

2.  Effects of inflammatory disease on plasma oxprenolol concentrations.

Authors:  M J Kendall; C P Quarterman; H Bishop; R E Schneider
Journal:  Br Med J       Date:  1979-08-25

3.  Bioavailability of beta-adrenoceptor blocking drugs.

Authors:  G Johnsson; C G Regardh
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

4.  Polymorphic metabolism of the beta-adrenoreceptor blocking drugs and its clinical relevance.

Authors:  R L Smith
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Trial of combination of guanethidine and oxprenolol in hypertension.

Authors:  R M Pearson; M R Bending; C J Bulpitt; C F George; D R Hole; F M Williams; A M Breckenridge
Journal:  Br Med J       Date:  1976-04-17

Review 6.  Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.

Authors:  G Johnsson; C G Regàrdh
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

7.  Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs.

Authors:  B K Park
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

8.  Pharmacokinetics and metabolism of a new beta-adrenergic blocking agent, the 1, ter-butyl-amino-3-(1,2,3,4-tetrahydro-1,4-ethano-8-hydroxy-5-naphthoxy)-2-propanol (K 5407).

Authors:  G Goldaniga; L Montesanti; E Pianezzola; G Valzelli
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

Review 9.  Antihypertensive drugs metabolism: an update to pharmacokinetic profiles and computational approaches.

Authors:  Aikaterini Zisaki; Ljubisa Miskovic; Vassily Hatzimanikatis
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.